Mark E Mcgovern - Net Worth and Insider Trading
Mark E Mcgovern Net Worth
The estimated net worth of Mark E Mcgovern is at least $8,150 dollars as of 2024-09-24. Mark E Mcgovern is the Director of Esperion Therapeutics Inc and owns about 5,000 shares of Esperion Therapeutics Inc (ESPR) stock worth over $8,150. Details can be seen in Mark E Mcgovern's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark E Mcgovern has not made any transactions after 2016-07-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark E Mcgovern
Mark E Mcgovern Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark E Mcgovern owns 1 companies in total, including Esperion Therapeutics Inc (ESPR) .
Click here to see the complete history of Mark E Mcgovern’s form 4 insider trades.
Insider Ownership Summary of Mark E Mcgovern
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ESPR | Esperion Therapeutics Inc | 2016-07-06 | director |
Mark E Mcgovern Latest Holdings Summary
Mark E Mcgovern currently owns a total of 1 stock. Mark E Mcgovern owns 5,000 shares of Esperion Therapeutics Inc (ESPR) as of July 6, 2016, with a value of $8,150.
Latest Holdings of Mark E Mcgovern
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ESPR | Esperion Therapeutics Inc | 2016-07-06 | 5,000 | 1.63 | 8,150 |
Holding Weightings of Mark E Mcgovern
Mark E Mcgovern Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark E Mcgovern has made a total of 0 transactions in Esperion Therapeutics Inc (ESPR) over the past 5 years. The most-recent trade in Esperion Therapeutics Inc is the acquisition of 5,000 shares on July 6, 2016, which cost Mark E Mcgovern around $50,000.
Insider Trading History of Mark E Mcgovern
- 1
Mark E Mcgovern Trading Performance
GuruFocus tracks the stock performance after each of Mark E Mcgovern's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark E Mcgovern is 31.61%. GuruFocus also compares Mark E Mcgovern's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark E Mcgovern within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark E Mcgovern's insider trading performs compared to the benchmark.
Performance of Mark E Mcgovern
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.46 | | | | | |
| Relative Return to S&P 500(%) | 4.5 | | | | | |
Mark E Mcgovern Ownership Network
Mark E Mcgovern Owned Company Details
What does Esperion Therapeutics Inc do?
Who are the key executives at Esperion Therapeutics Inc?
Mark E Mcgovern is the director of Esperion Therapeutics Inc. Other key executives at Esperion Therapeutics Inc include Chief Operating Officer Sheldon L. Koenig , Chief Commercial Officer Eric Warren , and Chief Medical Officer Joanne M. Foody .
Esperion Therapeutics Inc (ESPR) Insider Trades Summary
Over the past 18 months, Mark E Mcgovern made no insider transaction in Esperion Therapeutics Inc (ESPR). Other recent insider transactions involving Esperion Therapeutics Inc (ESPR) include a net sale of 7,687 shares made by Eric Warren , a net sale of 5,140 shares made by Joanne M. Foody , and a net purchase of 5,450 shares made by Sheldon L. Koenig .
In summary, during the past 3 months, insiders sold 18,394 shares of Esperion Therapeutics Inc (ESPR) in total and bought 0 shares, with a net sale of 18,394 shares. During the past 18 months, 28,667 shares of Esperion Therapeutics Inc (ESPR) were sold and 59,611 shares were bought by its insiders, resulting in a net purchase of 30,944 shares.
Esperion Therapeutics Inc (ESPR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Esperion Therapeutics Inc Insider Transactions
Mark E Mcgovern Mailing Address
Above is the net worth, insider trading, and ownership report for Mark E Mcgovern. Currently GuruFocus does not have mailing address information for Mark E Mcgovern.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
